US Bancorp
RXST icon

US Bancorp’s RxSight RXST Stock Holding History

US Bancorp’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-490
Closed -$3.02K – 4316
2026
Q1 		$3.02K Sell
490
-3
-0.6% -$25 ﹤0.01% 3710
2025
Q4 		$5.14K Buy
493
+126
+34% +$1.26K ﹤0.01% 3522
2025
Q3 		$3.3K Sell
367
-644
-64% -$5.65K ﹤0.01% 3654
2025
Q2 		$13.1K Buy
1,011
+801
+381% +$12K ﹤0.01% 3332
2025
Q1 		$5.3K Buy
210
+155
+282% +$4.61K ﹤0.01% 3636
2024
Q4 		$1.89K Sell
55
-25
-31% -$1.13K ﹤0.01% 3871
2024
Q3 		$3.96K Sell
80
-132
-62% -$6.76K ﹤0.01% 3644
2024
Q2 		$12.8K Sell
212
-313
-60% -$17.9K ﹤0.01% 3227
2024
Q1 		$27.1K Buy
525
+100
+24% +$4.91K ﹤0.01% 2970
2023
Q4 		$17.1K Buy
+425
New +$12.5K ﹤0.01% 3124

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

US Bancorp's RXST Position: Q2 2026 in Review

US Bancorp sold out of RxSight (RXST) in Q2 2026, closing a stake of 490 shares — an estimated $3.02K sold.

US Bancorp first reported a position in RXST in Q4 2023 and held it in 10 quarters. The position peaked at $27.1K in Q1 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • US Bancorp reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • US Bancorp sold 490 RxSight shares in Q2 2026, an estimated $3.02K.
  • US Bancorp first reported a position in RxSight in Q4 2023 and held it in 10 quarters.
  • US Bancorp's RxSight position peaked at $27.1K in Q1 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.